Home › Trial NCT05545436
Carrelizumab (PD-1) Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer
- Trial IDNCT05545436
- StatusUnknown
- PhasePhase 2
- Study typeInterventional
- SponsorThird Affiliated Hospital, Sun Yat-Sen University
- Enrollment34
- Start date2022-09-20
- ConditionsLocally Advanced Gastric Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.